LOXiGen ApS: Financial statements 2021
CVR: 41202793
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
LOXiGen ApS (CVR 41202793) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -8,575 and a net result of DKK -8,842 compared with DKK -25,200 the year before. Equity in the 2021 report amounted to DKK 5,958. The solvency ratio was 15.8%.
- Gross Profit
- DKK -8,575
- Profit/Loss
- DKK -8,842
- Equity
- DKK 5,958
- Total Assets
- DKK 37,733
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | -9 t. | -9 t. | 6 t. | 0 |
| 2020 | - | -25 t. | -25 t. | 15 t. | 0 |
Official annual report
Find more companies like LOXiGen ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
LOXiGen ApS has published its interim report for the period February 28, 2020 – December 31, 2020.
About LOXiGen ApS
LOXiGen ApS was a Danish company of the type Anpartsselskab based in Klampenborg, founded in 2020. The company has been dissolved on 30 June 2023. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. According to the 2021 annual report, the company had an average of 0 employees. In 2021, the company reported a gross profit of DKK -8,575 and a net result of DKK -8,842 compared with DKK -25,200 the year before. Equity in the 2021 report amounted to DKK 5,958.